Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-17-000286

Chief Medical Officer and SVP gave up 15,560 shares (to pay taxes)

  • Chief Medical Officer and SVP acquired 55,007 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Stromatt Scott C Chief Medical Officer and SVP 2017-03-01 Option exercise +16,269 45,894 D
Stromatt Scott C Chief Medical Officer and SVP 2017-03-01 Shares withheld for taxes −5,312 $2.02 $10,730 40,582 D
Stromatt Scott C Chief Medical Officer and SVP 2017-03-09 Option exercise +13,902 54,484 D
Stromatt Scott C Chief Medical Officer and SVP 2017-03-09 Shares withheld for taxes −3,678 $1.80 $6,620 50,806 D
Stromatt Scott C Chief Medical Officer and SVP 2017-03-10 Option exercise +24,836 75,642 D
Stromatt Scott C Chief Medical Officer and SVP 2017-03-10 Shares withheld for taxes −6,570 $1.78 $11,695 69,072 D
Derivatives
Stromatt Scott C Chief Medical Officer and SVP 2017-03-01 Option exercise · Restricted Stock Unit −16,269 190,672 D
Stromatt Scott C Chief Medical Officer and SVP 2017-03-09 Option exercise · Restricted Stock Unit −13,902 176,770 D
Stromatt Scott C Chief Medical Officer and SVP 2017-03-10 Option exercise · Restricted Stock Unit −24,836 151,934 D
Loading xslF345X03/stromatt_4.xml…